Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|October 12, 2022
The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)-results from the UK Sloane ProjectAbeer M Shaaban, Bridget Hilton, Karen Clements, et al.
Scientific Reports|March 29, 2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient seriesMatthew P Humphries, Sreekumar Sundara Rajan, Hedieh Honarpisheh, et al.
The Journal of Pathology|March 5, 2020
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancerSteven Hayward, Mariam Gachehiladze, Nahla Badr, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.
British Journal of Cancer|March 25, 2021
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) casesEmad A Rakha, Islam M Miligy, Cecily M Quinn, et al.
Breast Cancer Research and Treatment|November 19, 2011
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differencesAbeer M Shaaban, Graham R Ball, Rebecca A Brannan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term ResultsNigel Bundred, Nuria Porta, Adrian Murray Brunt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 24, 2026
A Worldwide Survey on Pathological Measurement of Residual Breast Cancer After Neoadjuvant Therapy: Different Interpretations of the ypTNM ClassificationKoen Kwakkenbos, Mieke R Van Bockstal, Abeer M Shaaban, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 15, 2022
Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex ImmunofluorescenceNahla M Badr, Jack L McMurray, Irini Danial, et al.
The British Journal of Radiology|January 24, 2024
Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia projectKaroline Freeman, Alice Mansbridge, Hilary Stobart, et al.
Pageof 11